Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women

20250 citationsJournal Articlediamond Open Access

Authors

Émeline Maisonneuve · University of Bern

Nicoletta Luxi · University of Verona

Chiara Bellitto · University of Verona

Francesco Ciccimarra · University of Verona

Monika Raethke · Netherlands Pharmacovigilance Centre Lareb

Florence van Hunsel · University of Groningen

Thomas Lieber

Abstract

This prospective study on COVID-19 vaccine safety monitoring showed that pregnant women from the general population reported solicited and unsolicited ADRs less frequently than non-pregnant women.

Topics & Keywords

COVID-19 Impact on Reproduction Pregnancy and Medication Impact Pharmacovigilance and Adverse Drug Reactions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Frontiers in Drug Safety and Regulation

Volume 5, pp. 1689349-1689349

DOI: 10.3389/fdsfr.2025.1689349

Field-Weighted Citation Impact: 0.00